R&D Q3 Clinical trials round-up: July to September 2025 As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.
News COVID-19 bites into Pfizer’s Q3, but biopharma revenues rise Pfizer is one of the front-runners in the race to approve a COVID-19 vaccine
News COVID-19 ventilator demand fuels Philips Q3 sales Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.